13G Filing: Sabby Capital and Onconova Therapeutics Inc. (ONTX)

Page 3 of 9 – SEC Filing

6.
SHARED VOTING POWER 86,5007.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 86,5009.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 86,50010.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)0.9412.
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

CO?

CUSIP No.
68232V1081.
NAME OF REPORTING PERSONSSabby Management, LLC2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)

(a) [_]

(b) [X]

3.
SEC USE ONLY4.
CITIZENSHIP OR PLACE OF ORGANIZATIONDelaware, USANUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

5.
SOLE VOTING POWER06.
SHARED VOTING POWER 789,3967.
SOLE DISPOSITIVE POWER08.
SHARED DISPOSITIVE POWER 789,3969.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 789,39610.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)

[_]11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

Follow Onconova Therapeutics Inc. (NASDAQ:ONTX)